Tiopronin (Tiopronin Delayed Release Tablets 1)
Tiopronin Tablet, Delayed Release
Product Images NDC 0254-3035
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tiopronin (NDC 0254-3035). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Endo Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Tiopronin Delayed-release Tablets (Tiopronin Delayed Release Tablets 2)
This text provides information about a medication with the National Drug Code (NDC) 0254-3034-30. The medicine is a delayed-release tablet containing 100 mg of tiopronin. It indicates the usual dosage may vary and recommends checking the prescribing information. The text also emphasizes keeping the medication and all drugs out of reach of children and provides storage instructions at 25°C (77°F) with permitted temperature excursions. It mentions that there are 300 tablets in the container and suggests storing per the USP Controlled Room Temperature guidelines.*
Tiopronin Delayed-release Tablets (Tiopronin Delayed Release Tablets 3)
This text provides information about Tiopronin Delayed-Release Tablets with NDC 0254-3035-09. Each tablet contains 300 mg of tiopronin. The usual dosage and storage instructions are included. The tablets are distributed by Par Pharmaceutical in Cranbury, NJ, USA. They are manufactured by Par Formulations Private Limited in India.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
